Filing Details
- Accession Number:
- 0001209191-21-009358
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-10 17:52:24
- Reporting Period:
- 2021-02-08
- Accepted Time:
- 2021-02-10 17:52:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 817720 | Synaptics Inc | SYNA | Semiconductors & Related Devices (3674) | 770118518 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1486742 | John Mcfarland | 1251 Mckay Drive San Jose CA 95131 | Svp, General Counsel & Sec. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-08 | 3,000 | $79.38 | 17,860 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-08 | 2,725 | $89.29 | 20,585 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-08 | 3,000 | $76.81 | 23,585 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-08 | 3,000 | $85.69 | 26,585 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-08 | 2,725 | $73.31 | 29,310 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-08 | 2,725 | $71.55 | 32,035 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-08 | 3,100 | $117.47 | 28,935 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-08 | 8,190 | $118.66 | 20,745 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-08 | 1,674 | $120.43 | 19,071 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-08 | 4,211 | $121.47 | 14,860 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-02-09 | 2,725 | $51.95 | 17,585 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-09 | 3,575 | $52.57 | 21,160 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-09 | 3,575 | $54.36 | 24,735 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-09 | 3,575 | $54.77 | 28,310 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-09 | 1,400 | $121.41 | 26,910 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-09 | 4,328 | $122.59 | 22,582 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-09 | 7,722 | $123.02 | 14,860 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-02-08 | 3,000 | $0.00 | 3,000 | $79.38 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-02-08 | 2,725 | $0.00 | 2,725 | $89.29 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-02-08 | 3,000 | $0.00 | 3,000 | $76.81 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-02-08 | 3,000 | $0.00 | 3,000 | $85.69 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-02-08 | 2,725 | $0.00 | 2,725 | $73.31 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-02-08 | 2,725 | $0.00 | 2,725 | $71.55 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-02-09 | 2,725 | $0.00 | 2,725 | $51.95 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-02-09 | 3,575 | $0.00 | 3,575 | $52.57 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-02-09 | 3,575 | $0.00 | 3,575 | $54.36 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-02-09 | 3,575 | $0.00 | 3,575 | $54.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-07-31 | No | 4 | M | Direct | |
| 0 | 2022-10-23 | No | 4 | M | Direct | |
| 0 | 2022-01-30 | No | 4 | M | Direct | |
| 0 | 2022-04-24 | No | 4 | M | Direct | |
| 0 | 2023-01-29 | No | 4 | M | Direct | |
| 0 | 2023-04-29 | No | 4 | M | Direct | |
| 0 | 2023-07-29 | No | 4 | M | Direct | |
| 0 | 2023-10-28 | No | 4 | M | Direct | |
| 0 | 2024-01-27 | No | 4 | M | Direct | |
| 0 | 2024-04-28 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.92 to $117.79,inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118 to $118.94,inclusive. The reporting person undertakes to provide to Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.92 to $120.79,inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.928 to $121.740, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.95 to $121.91,inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122 to $122.96,inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123 to $123.14,inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the July 31, 2015 date of grant, until fully vested on July 31, 2018.
- 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the October 23, 2015 date of grant, until fully vested on October 23, 2018.
- 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 30, 2015 date of grant, until fully vested on January 30, 2018.
- 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the April 24, 2015 date of grant, until fully vested on April 24, 2018.
- 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 29, 2016 date of grant, until fully vested on January 29, 2019.
- 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the April 29, 2016 date of grant, until fully vested on April 29, 2019.
- 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the July 29, 2016 date of grant, until fully vested on July 29, 2019.
- 33% of the total number of shares subject to the option vested and became exercisable one year following the vesting commencement date of October 28, 2016, with the remaining 2/3rds vesting quarterly until fully vested on October 28, 2019.
- 33% of the total number of shares subject to the option vested and became exercisable one year following the vesting commencement date of January 27, 2017,with the remaining 2/3rds vesting quarterly until fully vested on January 27, 2020.
- 33% of the total number of shares subject to the option vested and became exercisable one year following the vesting commencement date of April 28, 2017, with the remaining 2/3rds vesting quarterly until fully vested on April 28, 2020.
Billionaire Hedge Funds
